Svetlana Mosteoru

Cardiologist passionate about research

[Svetlana Mosteoru @SMosteoru]

Female power United in Prevention! Listen to the great ideas the presidents of the ESC Associations have shared in an amazing session at #ESCPrev2025
#escprevmotions
@EAPCPresident @denisamuraru
@PTBuketAkinci @AnastasiaSMihai

[EJPC Editor-in-Chief @EJPCEiC]

Oral PCSK9 inhibitors 💊 demonstrate potent LDL-C–lowering efficacy, comparable to parenteral PCSK9i, with favourable effects on other atherogenic lipids 👉https://t.co/j89zcriQf1

@escardio @AboyansV @SilCastelletti @PeroneFrancesco @PTBuketAkinci @SMosteoru @TimKambic

[European Society of Cardiology Journals @ESC_Journals]

🧪 Target Trial Emulation (TTE) is reshaping cardiovascular real-world evidence.
By designing observational studies to mimic hypothetical RCTs, TTE helps reduce avoidable bias and strengthen causal interpretation in clinical research.
🫀📊https://t.co/2YsQ1iPLFR

#EJPC
@EJPCEiC @AboyansV @SilCastelletti @PTBuketAkinci @PeroneFrancesco @SMosteoru @TimKambic

[EJPC Editor-in-Chief @EJPCEiC]

Even before diabetes develops, dysglycaemia may increase AF risk. ⚠️
A meta-analysis including 26.4 million participants showed that prediabetes was associated with ⬆️15% risk of AF, supporting a dose–response relationship across glucose levels.
🔗https://t.co/KhJ8mp845N

[Svetlana Mosteoru @SMosteoru]

Exercise may reduce risk of ASCVD by 50%, but is not a substitute for established medical therapy!
#EASCongress2026
@MichaelPapadak2

[EJPC Editor-in-Chief @EJPCEiC]

🏃‍♂️ More than 1 in 3 athletes show elevated cardiac troponin levels after exercise. This meta-analysis highlights that elevations are most common after endurance events lasting 3–6 h and with high-sensitivity cTnT assays.🫀
🔗https://t.co/JvL7v7N9gj
#sportscardiology

[Svetlana Mosteoru @SMosteoru]

Transatlantic dyslipidemia guidelines recommendations!
#EASCongress2026

[Cherska Mariia @cherskams]

Great science matters — but so do the people, collaborations, and conversations that make the EAS community special.

Who are you excited to see at #EASCongress2026?

#EAS2026 #RoadToEASCongress2026

[Svetlana Mosteoru @SMosteoru]

Plasma Lp(a) concentrations predict incident aortic stenosis and progression
#EASCongress2026

[European Society of Cardiology Journals @ESC_Journals]

New in #EJPC: Cuffless Blood Pressure Monitoring Devices: Technical Foundations and Clinical Implications: Scientific Statement of the European Society of Cardiology (ESC) Working Group on e-Cardiology, the ESC Council on Hypertension, and the European Association of Preventive Cardiology of the ESC
https://t.co/9sFxL5OtLg

@EJPCEiC @AboyansV @SilCastelletti @PTBuketAkinci @PeroneFrancesco @SMosteoru @TimKambic

[Svetlana Mosteoru @SMosteoru]

The genetic paradox
#EASCongress2026

[Svetlana Mosteoru @SMosteoru]

Should we move from the dichotomy of primary and secondary prevention? Check out the results of the Vesalius trial
#EASCongress2026

[EAS Congress @EASCongress]

We’re kicking off the #EASCongress2026 Scavenger Hunt with the first hint!

Find a first envelope and win a special experience in Gothenburg, Sweden - the host city of EAS Congress 2027.

🔗 Find out more about the scavenger hunt: https://t.co/LVlm4JewON

#Atherosclerosis

[Svetlana Mosteoru @SMosteoru]

EAS has already started ...
Who is at Risk of Cardiovascular Events? Join this amazing session now!
#EAS2026
#EASCongress2026
#MyEAS2026

[Federica Fogacci @FedericaFogacci]

Sunday morning congress prep: download the #EASCongress2026 app before the first sessions start
Your future self, trying to be in three places at once, will thank you :)
🔗https://t.co/lHm05zsvY9
@EASCongress @society_eas #EASSoMe #MyEAS2026

[EJPC Editor-in-Chief @EJPCEiC]

Resistant hypertension remains a high-risk condition but lower BP targets may help.
The STEP trial analysis found intensive BP control (<130 mmHg) was associated with substantially fewer cardiovascular events (64% ⬇️), without added safety concerns.
https://t.co/3DAe7gsFUO

[EJPC Editor-in-Chief @EJPCEiC]

New from the Hordaland Health Study: elevated BP in early midlife was linked to greater arterial stiffness 27 years later in women but not in men. A powerful signal for earlier and sex-specific cardiovascular prevention. 🫀♀️
https://t.co/VSWPerHOOd

[Svetlana Mosteoru @SMosteoru]

It's worth participating! Don't hesitate to register!

[European Atherosclerosis Society @society_eas]

We’re ready to announce another Rare Lipid Disorder Course! This time, Argentina 🇦🇷 invites all LatAm members to Buenos Aires to learn from leading experts in the field. Check out the fantastic programme and speaker line-up. After that, register to secure your spot: https://t.co/UfkDmqke5Y @lschreier1 @drpablocorral

[EJPC Editor-in-Chief @EJPCEiC]

New issue of #EJPC released for “World Hypertension Day” is focused on HT care from precision BP phenotyping and vascular ageing to cuffless monitoring, digital health, renal denervation, and sex-specific prevention strategies.
🔗https://t.co/noGBKcJShV